Podcast Index
Explora podcasts por categoría, abre episodios recientes y descarga audio para escucharlo sin conexión.
Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
Prophetic Breakthrough for Christian Women - Clarity, Trust in God, Overthinking, God’s Plan, Discernment, Transformation
Amy Wadlington - Christian Life Coach, Prophetic Life Coaching, Spiritual Growth Mentor
CFO Podcast
Peter De Roeck
Climate Watch
China Plus
Texas Longhorns Football Today | 2 Min News | The Daily News Now!
The Daily News Now!
ITGELRADIO
Itgelradio
All In with Chris Hayes
MS NOW, Chris Hayes
700 WLW On-Demand
WLW-AM (WLWAM)
On Texas Football
Bobby Burton
LES OUTSIDERZ
Stan Diop
Artificial Intelligence Masterclass
AI Masterclass
Boise News Today | 2 Min News | The Daily News Now!
The Daily News Now!
SELF LOVE Podcast With Raymond Cole
LC GRAYS
Los Angeles News Today | 2 Min News | The Daily News Now!
The Daily News Now!
Baton Rouge News Today | 2 Min News | The Daily News Now!
The Daily News Now!
Canada News Today | 2 Min News | The Daily News Now!
The Daily News Now!
Astros Baseball Podcast
MinuteMedia Podcasts
Locked On Giants - Daily Podcast On The New York Giants
Locked On Podcast Network, Patricia Traina
Dirty Linen - A Food Podcast with Dani Valent
A Deep in the Weeds Production
On the Record - Reporter.lu
Reporter.lu
Hapa英会話 Podcast
Jun Senesac: バイリンガル 英会話 & ビジネス英語 講師
Raj Prakash Paul
Raj Prakash Paul
China In Focus
Epoch Media Group
बालमोदिनी
सम्भाषणसन्देशः
After Skool
After Skool
artificially aware
Artificially Aware
Quazi Johir
Quazi Johir
Tina Huang
Tina Huang
Tripp After Dark
Tripp Fontane
Dr. Pradip Jamnadas, MD
Dr. Pradip Jamnadas, MD
Dr. Ken Berry - The Proper Human Diet & Ancestral Health
Dr. Ken Berry MD
ReddX Reddit Reads
ReddX
RipeStories
Ripe
THE MIC'D UP MISFITS
The FAN Owatonna
The 'X' Zone Radio/TV Show
REL-MAR McConnell Media Company - www.rel-mar.com
P’s Chocolate Talk (Seasons 2-12)
👑👑👑👑 P
Sweet Dreams Bedtime Stories
FluentFiction.org
Todo
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
The cell and gene therapy industry faces massive hurdles—cost, scalability, and the need for highly skilled operators have historically limited the reach of these transformative treatments. advanced therapy medicinal pro...
What if the simple act of opening an incubator could undermine the consistency of your cell therapy manufacturing process? Unlike traditional biologics, the moment cells leave their incubator, subtle shifts in temperatur...
Digital transformation in biotech is no longer just about adopting new tools, it's about building a foundation where automation, data standardization, and AI integration actually lead to real value and long-term success....
Despite cutting-edge equipment and brilliant minds, biotech labs often find half their data trapped in difficult-to-access spreadsheets or isolated in silos, making true digital transformation a major, industry-wide hurd...
Host David Brühlmann returns for a focused solo episode to provide an honest, data-driven perspective on the evolving landscape of host selection for biologics manufacturing. Building on part one, David reviews five alte...
In this solo episode, David Brühlmann explores the evolving landscape of biologic manufacturing platforms beyond CHO (Chinese hamster ovary) cells. Drawing from previous interviews with platform pioneers and rigorous dat...
Funding novel therapeutics isn’t just “harder than ever”—the rules have changed entirely. The wild rush of capital into early-stage biotech during 2020–2021 gave way to a drought, making investor priorities sharper and s...
Strong science alone won’t get your biotech startup funded—investors are sizing up much more than just your molecule.Michael Rome, who leads therapeutics investing at Foresite Capital, brings a rare dual lens as both sci...
What happens between scientific discovery and clinical trials? For too many drug candidates, the answer is “failure”—not because the idea lacked merit, but because the critical handoff between discovery and IND-enabling ...
The gap between a “drug” and a true “product” is where many therapies fail.Milan Tomic, biotech veteran, GMP manufacturing expert, and founder of Albrem, has spent 30 years turning promising science into scalable, execut...
The "data lake" that was supposed to unify bioprocessing intelligence has, in most companies, become something else entirely: a data swamp, where information goes in and insight rarely comes back out. For anyone trying t...
When AI can draft a literature review in minutes, the question bioprocess educators can no longer avoid is this: what does a student actually need to learn?Steffen Kreye has a clear answer. As Professor of Industrial Bio...
Can aging be fundamentally slowed or even reversed—not by science fiction, but by harnessing the unassuming power of super-early stem cells?In Part 1, Yuta Lee, Founder and CEO of Accelerated Bio, walked through the biol...
What if the key to scalable, off-the-shelf cell therapy was hiding in tissue that surgeons discard every day?Yuta Lee, Founder and CEO of Accelerated Bio, has spent two decades building a cell therapy platform on exactly...
Are you still using one-factor-at-a-time experiments for biosimilar development, losing months, missing interactions, and risking costly dead-ends?In this episode, David Brühlmann, host of the Smart Biotech Scientist Pod...
Are you stuck screening endless compounds in biosimilar development and still not hitting your quality targets? Efficient compound screening is one of the toughest bottlenecks in biopharma, with outdated methods slowing ...
When every batch belongs to a single patient, a single centralized facility cannot serve the world. In Part 2, Chantale Bernatchez moves from process development into the broader consequences of that reality: the manufac...
The most underappreciated parameter in cell therapy process development is not your bioreactor, your media, or your activation protocol. It is the patient. Chantale Bernatchez has spent 20 years learning that lesson the ...
Getting an NDA signed shouldn't take weeks. If your CRO needs more than 48 hours to start the paperwork, your project timeline is already moving in the wrong direction.Ron Najafi knows what rigorous analytical work actua...
When drug safety fails, patients and entire markets pay the price. Understanding your CMC isn't just compliance — it's the line between therapeutic promise and product recall.Ron Najafi has lived that reality firsthand. ...
Completa el formulario de abajo. Asegúrate de seleccionar tanto País como Géneros.
Envíanos un mensaje abajo. Te responderemos en un plazo de 24 horas.